Viridian Therapeutics, Inc.

NasdaqCM VRDN

Viridian Therapeutics, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2024: USD -283.04 M

Viridian Therapeutics, Inc. Operating Income is USD -283.04 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -21.98% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Viridian Therapeutics, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -232.04 M, a -102.97% change year over year.
Viridian Therapeutics, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -114.32 M, a 19.06% change year over year.
Viridian Therapeutics, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -141.25 M, a -373.14% change year over year.
Viridian Therapeutics, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -29.85 M, a 29.53% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

NasdaqCM: VRDN

Viridian Therapeutics, Inc.

CEO	Mr. Stephen F. Mahoney J.D., MBA
IPO Date	June 18, 2014
Location	United States
Headquarters	221 Crescent Street
Employees	94
Sector	Health Care
Industries Biotechnology Clinical Trials Pharmaceuticals

Description

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Key trends

Past 5 years